Filing Details
- Accession Number:
- 0001209191-21-014749
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-26 16:23:27
- Reporting Period:
- 2021-02-24
- Accepted Time:
- 2021-02-26 16:23:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-24 | 864 | $217.57 | 15,964 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-02-25 | 244 | $211.80 | 15,720 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 452 | $213.12 | 15,268 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 258 | $214.32 | 15,010 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 126 | $216.25 | 14,884 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $211.80 (range $211.57 to $212.07).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $213.12 (range $212.82 to $213.79).
- Open market sales reported on this line occurred at a weighted average price of $214.32 (range $213.90 to $214.69).
- Open market sales reported on this line occurred at a weighted average price of $216.25 (range $215.79 to $216.76).
Billionaire Hedge Funds
